Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury.

Calfee CS, Ware LB, Glidden DV, Eisner MD, Parsons PE, Thompson BT, Matthay MA. Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med. 2011 Apr; 39(4):711-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.